• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Opinion
    • Global Health

    Opinion: At the epicenter of the HIV epidemic, we still need PEPFAR

    While the future of PEPFAR remains in the balance, this account from South Africa’s Dhirisha Naidoo shows how successful PEPFAR has been and what is at stake if we lose focus on ending HIV as a public health threat by 2030.

    By Dhirisha Naidoo // 03 November 2023

    I had a profound experience when I visited Washington, D.C. in mid-September to address decision-makers from Capitol Hill ahead of the reauthorization deadline of PEPFAR, the United States’ flagship global program on HIV/AIDS.

    It was the day before our meeting and I had the chance to walk past the Lincoln Memorial and the White House, and even the U.S. Agency for International Development offices. I became overwhelmed by the generosity of the American people for funding the programs that made it possible for me to serve my country through its worst public health crisis, the HIV/AIDS epidemic. A journey through the darkest days imaginable to the hope we see today.

    So, while the PEPFAR five-year reauthorization deadline passed and the program’s future remains in political discussion, I am sharing my story from the epicenter of the HIV epidemic to remind everyone of how far we have come, just how successful PEPFAR has been from the local perspective, and what is at stake if we lose focus on ending HIV as a public health threat by 2030.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    More reading:

    ► What ‘extremism’ in US politics means for PEPFAR’s future (Pro)

    ► PEPFAR chief rejects abortion funding allegations

    ► Abortion politics cast shadow over PEPFAR reauthorization

    • Global Health
    • Social/Inclusive Development
    • Trade & Policy
    • Funding
    • BroadReach Group
    • PEPFAR
    • APACE
    • South Africa
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    The views in this opinion piece do not necessarily reflect Devex's editorial views.

    About the author

    • Dhirisha Naidoo

      Dhirisha Naidoo

      Dhirisha Naidoo is chief of party for the BroadReach APACE program in South Africa, a PEPFAR-funded USAID HIV treatment and care program. Starting out as a nurse 20 years ago in one of the first PEPFAR-backed clinics in SA, today she leads one of USAID’s largest HIV programs globally.

    Search for articles

    Related Stories

    Global healthWhy PEPFAR has bigger problems than reauthorization

    Why PEPFAR has bigger problems than reauthorization

    Global healthHow economic resilience projects are helping HIV patients survive aid cuts

    How economic resilience projects are helping HIV patients survive aid cuts

    Global HealthA month after stop-work order, Uganda’s HIV response in chaos

    A month after stop-work order, Uganda’s HIV response in chaos

    Devex NewswireDevex Newswire: PEPFAR expires today, but real test is still to come

    Devex Newswire: PEPFAR expires today, but real test is still to come

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 4
      How is China's foreign aid changing?
    • 5
      2024 US foreign affairs funding bill a 'slow-motion gut punch'
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement